Search Results - Read, Jessica
- Showing 1 - 7 results of 7
-
1
-
2
-
3
-
4
-
5
-
6
Vandetanib in Patients With Locally Advanced or Metastatic Medullary Thyroid Cancer: A Randomized, Double-Blind Phase III Trial by Wells, Samuel A., Robinson, Bruce G., Gagel, Robert F., Dralle, Henning, Fagin, James A., Santoro, Massimo, Baudin, Eric, Elisei, Rossella, Jarzab, Barbara, Vasselli, James R., Read, Jessica, Langmuir, Peter, Ryan, Anderson J., Schlumberger, Martin J.
Published 2012Text -
7
A retrospective analysis of RET translocation, gene copy number gain and expression in NSCLC patients treated with vandetanib in four randomized Phase III studies by Platt, Adam, Morten, John, Ji, Qunsheng, Elvin, Paul, Womack, Chris, Su, Xinying, Donald, Emma, Gray, Neil, Read, Jessica, Bigley, Graham, Blockley, Laura, Cresswell, Carl, Dale, Angela, Davies, Amanda, Zhang, Tianwei, Fan, Shuqiong, Fu, Haihua, Gladwin, Amanda, Harrod, Grace, Stevens, James, Williams, Victoria, Ye, Qingqing, Zheng, Li, de Boer, Richard, Herbst, Roy S, Lee, Jin-Soo, Vasselli, James
Published 2015Text